I don't think AI demand is broken yet. I’m watching actual orders, cash flow and funding much more closely, especially for companies like $CoreWeave, Inc.(CRWV)$ and $NEBIUS(NBIS)$ . Genuine end-demand is very different from growth that depends on continuous financing.
So I see this as a healthy warning rather than an AI collapse. The sell-off may be too aggressive for some names, but this earnings season, I’ll focus more on backlog quality, funding and free cash flow than headline revenue growth. 📊
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- BertScott·08-20 17:53TOPI get the healthy warning angle, but NVDA's valuation still doesn't look like it has fully priced the funding risk. Feels more like the financing froth finally getting squeezed.LikeReport
